Accolade Inc

Análisis de la acción Accolade Inc (ACCD)

$7.020

-0.010 (-0.14%)Al cierre

Loading chart…
Máximo
7.030
Apertura
7.030
Precio medio ponderado por volumen
7.02
Volumen
4.59M
Capitalización
511.25M
Mínimo
7.010
Importe
32.19M
EV/EBITDA, TTM
16.63

Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.

www.accolade.com

Métricas de valoración

El PER previsto actual de Accolade Inc (ACCD) es -50.82, frente a su media de 5 años de -18.90.

PER previsto

Muy infravalorado
Media 5A P/E
-18.90
P/E actual
-50.82
Sobrevalorada
-8.25
Infravalorada
-29.56

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-23.89
EV/EBITDA actual
16.63
Sobrevalorada
122.46
Infravalorada
-170.23

Precio/ventas previsto

Valor razonable
Media 5A P/S
1.98
P/S actual
1.10
Sobrevalorada
3.30
Infravalorada
0.66

Cronología de eventos

2025-04-22 (ET)

08:30:04

Thirteen option delistings on April 22nd

2025-03-27 (ET)

16:21:57

Accolade announces stockholder approval for Transcarent merger

2025-02-24 (ET)

17:22:32

Accolade and Transcarent announce HSR waiting period expiration for merger

2025-01-13 (ET)

06:08:49

Accolade downgraded to Hold from Buy at Truist

2025-01-08 (ET)

12:15:09

Accolade downgraded to Hold from Buy at Needham

Noticias

Preguntas frecuentes sobre ACCD, respondidas por Alphio AI

Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One. It operates in the Healthcare sector (SERVICES-BUSINESS SERVICES, NEC industry).

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar